Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects

References

• Angulo P. alcoholic fatty liver disease. N Engl J Med 2002;346:1221–31
   PubMed Web of Science ®Google Scholar
• Jimba S, Nakagami T, Takahashi M, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005;22:1141–5
   PubMed Web of Science ®Google Scholar
• Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009;50:204–10
   PubMed Web of Science ®Google Scholar
• Amarapurkar DN, Hashimoto E, Lesmana LA, et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007;22:788–93
   PubMed Web of Science ®Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387–95
   PubMed Web of Science ®Google Scholar
• Suzuki A, Lindor K, St Saver J, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005;43:1060–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Li YY, Nie YQ, et al. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Exp Ther Med 2013;6:77–84
   PubMed Web of Science ®Google Scholar
• Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003;163:1301–11
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844–50
   PubMed Web of Science ®Google Scholar
• Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 2012;96:269–81
   PubMed Web of Science ®Google Scholar
• Pagadala MR, Zein CO, Dasarathy S, et al. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig Dis Sci 2012;57:528–34
   PubMed Web of Science ®Google Scholar
• Chung GE, Kim D, Kim W, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol 2012;57:150–6
   PubMed Web of Science ®Google Scholar
• Xu C, Xu L, Yu C, et al. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxf) 2011;75:240–6
   PubMed Web of Science ®Google Scholar
• Fan JG, Jia JD, Li YM, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010. Chin J Hepatol 2010;18:163–6. J Dig Dis 2011;12:38–44 (in Chinese)
   PubMedGoogle Scholar
• Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
   Google Scholar
• Targher G, Montagnana M, Salvagno G, et al. Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. Clin Endocrinol (Oxf) 2008;68:481–4
   PubMed Web of Science ®Google Scholar
• Ittermann T, Haring R, Wallaschofski H, et al. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid 2012;22:568–74
   PubMed Web of Science ®Google Scholar
• Eshraghian A, Dabbaghmanesh MH, Eshraghian H, et al. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med 2013;16:584–9
   PubMed Web of Science ®Google Scholar
• Kim BJ, Kim TY, Koh JM, et al. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf) 2009;70:152–60
   PubMed Web of Science ®Google Scholar
• Roos A, Bakker SJ, Links TP, et al. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007;92:491–6
   PubMed Web of Science ®Google Scholar
• Lin SY, Wang YY, Liu PH, et al. Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metabolism 2005;54:1524–8
   PubMed Web of Science ®Google Scholar
• Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2005;21:702–7
   PubMed Web of Science ®Google Scholar
• Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 2009;27:339–62
   PubMed Web of Science ®Google Scholar
• Wang F, Tan Y, Wang C, et al. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. J Clin Endocrinol Metab 2012;97:2724–31
   PubMed Web of Science ®Google Scholar
• Fox CS, Pencina MJ, D'Agostino RB, et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 2008;168:587–92
   PubMedGoogle Scholar
• Ruhla S, Weickert MO, Arafat AM, et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 2010;72:696–701
   PubMed Web of Science ®Google Scholar
• Zhang W, Tian LM, Han Y, et al. Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription. J Cell Mol Med 2009;13:4636–42
   PubMed Web of Science ®Google Scholar
• Tian L, Song Y, Xing M, et al. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology 2010;52:1401–9
   PubMed Web of Science ®Google Scholar
• Sorisky A, Bell A, Gagnon A. TSH receptor in adipose cells. Horm Metab Res 2000;32:468–74
   PubMed Web of Science ®Google Scholar
• Valyasevi RW, Harteneck DA, Dutton CM, et al. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 2002;87:2352–8
   PubMed Web of Science ®Google Scholar
• Lu S, Guan Q, Liu Y, et al. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis 2012;11:17 . http://www.lipidworld.com/content/11/1/17
   PubMed Web of Science ®Google Scholar
• Menendez C, Baldelli R, Camiña JP, et al. TSH stimulates leptin secretion by a direct effect on adipocytes. J Endocrinol 2003;176:7–12
   PubMed Web of Science ®Google Scholar
• Santini F, Galli G, Maffei M, et al. Acute exogenous TSH administration stimulates leptin secretion in vivo. Eur J Endocrinol 2010;163:63–7
   PubMed Web of Science ®Google Scholar